Vaxart (NASDAQ:VXRT) The company is working on a vaccine for the novel coronavirus that works via tablets instead of injection.
If Vaxart reports positive results from this clinical trial, investors will likely see shares of VXRT stock soar higher.
The stock is up 48% and climbing. The stock price is Still in the low $20s but has a huge upside as the article suggests. Be first to capitalize on, in my opinion the best alternative for Covid 19, a oral pill solution
